Viveve Medical, Inc.
VIVE · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $6,426 | $5,479 | $6,567 | $18,517 |
| % Growth | 17.3% | -16.6% | -64.5% | – |
| Cost of Goods Sold | $5,806 | $5,183 | $5,551 | $11,197 |
| Gross Profit | $620 | $296 | $1,016 | $7,320 |
| % Margin | 9.6% | 5.4% | 15.5% | 39.5% |
| R&D Expenses | $9,665 | $5,125 | $8,590 | $13,716 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12,508 | $13,666 | $22,363 | $38,569 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $13 |
| Operating Expenses | $22,173 | $18,791 | $30,953 | $52,285 |
| Operating Income | -$21,553 | -$18,495 | -$29,937 | -$44,965 |
| % Margin | -335.4% | -337.6% | -455.9% | -242.8% |
| Other Income/Exp. Net | -$218 | -$3,037 | -$11,220 | -$4,359 |
| Pre-Tax Income | -$21,771 | -$21,532 | -$41,899 | -$49,324 |
| Tax Expense | $256 | $383 | $4,820 | -$142 |
| Net Income | -$22,027 | -$21,915 | -$42,526 | -$49,182 |
| % Margin | -342.8% | -400% | -647.6% | -265.6% |
| EPS | -2.65 | -16.56 | -121.91 | -1,583.5 |
| % Growth | 84% | 86.4% | 92.3% | – |
| EPS Diluted | -2.65 | -16.56 | -121.91 | -1,583.5 |
| Weighted Avg Shares Out | 10,090 | 1,574 | 383 | 31 |
| Weighted Avg Shares Out Dil | 10,090 | 1,574 | 383 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,000 | $910 | $4,354 | $4,372 |
| Depreciation & Amortization | $1,139 | $1,297 | $1,182 | $786 |
| EBITDA | -$19,632 | -$19,325 | -$30,679 | -$44,166 |
| % Margin | -305.5% | -352.7% | -467.2% | -238.5% |